It is believed, however, that idiopathic Parkinson’s disease is linked to a body’s problems with using a certain protein. Symptoms of Parkinson’s can include tremors, often in the hands or ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment strategies.

In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, ...

Gain Therapeutics (GANX) provided a letter to shareholders from the Company’s President and CEO, Gene Mack, which read in part,”With 2025 ...

Degeneration of this structure is characteristic of Parkinson's disease. In late 2018, Japanese neurosurgeons at Kyoto University Hospital implanted reprogrammed stem cells into the brain of a ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and ...

In December 2024, we received approval to initiate our Phase 1b clinical trial of GT-02287 in people with GBA1 or idiopathic Parkinson’s disease. This followed the completion of our study in healthy ...

The Phase 1b open-label trial will assess the safety and tolerability of 13.5 mg/kg/day of GT-02287 for three months in patients with GBA1-PD or idiopathic Parkinson’s disease. Secondary endpoints ...

The typical idiopathic PD patient presents with asymmetrical ... The Core Assessment Program for Surgical Interventional Therapies in Parkinson's disease recommends that a battery of cognitive ...

Bob Biljetina has been a member of the Parksville Table Tennis Society for four years now. It's an important recreational ...